Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
For Journalists
Media Coordinator
Telephone: 412-692-6254
Director
Telephone: 412-877-1656
Other Inquiries

 

Children’s Hospital of Pittsburgh of UPMC Clinical Trial Aims to Prevent Type 2 Diabetes in Youth through Medication

PITTSBURGH, May 22, 2013 – A clinical trial being conducted at Children’s Hospital of Pittsburgh of UPMC will examine whether type 2 diabetes can be prevented or slowed in high-risk youth by treating them with diabetes medications before they have the full-blown disease.

The Restoring Insulin Secretion Study: RISE Pediatric Medication Study (RISE) is currently enrolling overweight/obese adolescents who have prediabetes or have been recently diagnosed with type 2 diabetes. RISE will examine the effects of two medications: metformin and insulin. The expectation is that the use of these medications before diabetes has developed will preserve or enhance the body’s ability to produce insulin, the hormone that is crucial to maintaining normal blood sugar levels.

“RISE aims to identify young people who are at high risk for developing diabetes and then treat them with medications for a few months to prevent its development,” said Silva Arslanian M.D., pediatric endocrinologist and diabetologist, chief, Weight Management and Wellness Center at Children’s Hospital, professor of pediatrics at the University of Pittsburgh School of Medicine and principal investigator of RISE. “We also want to try to determine if those with a short duration of diabetes of a few months might benefit from treatment with these medications. In both cases, the goal is to attempt to prevent loss of, or even restore, insulin secretion by the pancreas.”

“Our findings from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) trial indicate that type 2 diabetes may be more difficult to treat in teenagers than in adults,” said Dr. Arslanian, who has been the principal investigator of the Pittsburgh site for the TODAY trial for the past 12 years. “Unlike adults, their disease seems to be more aggressive and less responsive to available standard treatments. It is imperative that we build upon our findings from the TODAY trial to find treatment alternatives so these young people can stay healthier longer.”

Children’s Hospital is one of four sites recruiting adolescents and young adults for participation in the RISE pediatric medication study; the others are Yale University, Indiana University and Children’s Hospital Colorado.

The RISE study, sponsored by the National Institutes of Health, is currently recruiting participants to take part in the research study at the Pediatric Clinical and Translational Research Center (PCTRC) at Children’s Hospital. The PCTRC is a unique multidisciplinary setting that gives physicians the opportunity to investigate childhood diseases in a controlled environment in both an inpatient and outpatient basis. To be eligible for the study, participants must be between 10 and 19 years of age, have prediabetes or type 2 diabetes for less than six months, and be overweight.

RISE is supported under NIH grants U01DK94430, U01DK94431, U01DK94406, U01DK94438 and U01DK94467.

For more information about this study, please contact a member of the RISE study team at 412-692-5846 or visit www.chp.edu/rise

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com